Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation
- PMID: 28807677
- PMCID: PMC5797427
- DOI: 10.1016/j.neuropharm.2017.08.011
Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation
Abstract
It is increasingly evident that alcohol-induced, gut-mediated peripheral endotoxemia plays a significant role in glial cell activation and neuro-inflammation. Using a mouse model of chronic alcohol feeding, we examined the causal role of endotoxin- and cytokine-responsive Pde4 subfamily b (Pde4b) expression in alcohol-induced neuro-inflammation. Both pharmacologic and genetic approaches were used to determine the regulatory role of Pde4b. In C57Bl/6 wild type (WT) alcohol fed (WT-AF) animals, alcohol significantly induced peripheral endotoxemia and Pde4b expression in brain tissue, accompanied by a decrease in cAMP levels. Further, along with Pde4b, there was a robust activation of astrocytes and microglia accompanied by significant increases in the inflammatory cytokines (Tnfα, Il-1β, Mcp-1 and Il-17) and the generalized inflammatory marker Cox-2. At the cellular level, alcohol and inflammatory mediators, particularly LPS, Tnfα and Hmgb1 significantly activated microglial cells (Iba-1 expression) and selectively induced Pde4b expression with a minimal to no change in Pde4a and d isoforms. In comparison, the alcohol-induced decrease in brain cAMP levels was completely inhibited in WT mice treated with the Pde4 specific pharmacologic inhibitor rolipram and in Pde4b-/- mice. Moreover, all the observed markers of alcohol-induced brain inflammation were markedly attenuated. Importantly, glial cell activation induced by systemic endotoxemia (LPS administration) was also markedly decreased in Pde4b-/- mice. Taken together, these findings strongly support the notion that Pde4b plays a critical role in coordinating alcohol-induced, peripheral endotoxemia mediated neuro-inflammation and could serve as a significant therapeutic target.
Keywords: Alcohol; Microglial activation; Neuroinflammation; Pde4b; Rolipram (PubChem CID: 5092); cAMP.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures








Similar articles
-
Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.J Pathol. 2016 Sep;240(1):96-107. doi: 10.1002/path.4760. J Pathol. 2016. PMID: 27287961 Free PMC article.
-
Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.Sci Rep. 2017 Apr 6;7:46165. doi: 10.1038/srep46165. Sci Rep. 2017. PMID: 28383060 Free PMC article.
-
Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia.Neurobiol Dis. 2019 Apr;124:353-363. doi: 10.1016/j.nbd.2018.12.008. Epub 2018 Dec 14. Neurobiol Dis. 2019. PMID: 30557659 Free PMC article.
-
PDE4B as a microglia target to reduce neuroinflammation.Glia. 2016 Oct;64(10):1698-709. doi: 10.1002/glia.22986. Epub 2016 Apr 1. Glia. 2016. PMID: 27038323 Review.
-
PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.Curr Radiopharm. 2011 Jan;4(1):44-58. doi: 10.2174/1874471011104010044. Curr Radiopharm. 2011. PMID: 22191614 Review.
Cited by
-
Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis.Drug Des Devel Ther. 2022 May 3;16:1301-1309. doi: 10.2147/DDDT.S355796. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35535222 Free PMC article.
-
Exacerbating effects of single-dose acute ethanol exposure on neuroinflammation and amelioration by GPR110 (ADGRF1) activation.J Neuroinflammation. 2023 Aug 14;20(1):187. doi: 10.1186/s12974-023-02868-w. J Neuroinflammation. 2023. PMID: 37580715 Free PMC article.
-
Predation threats for a 24-h period activated the extension of axons in the brains of Xenopus tadpoles.Sci Rep. 2020 Jul 16;10(1):11737. doi: 10.1038/s41598-020-67975-7. Sci Rep. 2020. PMID: 32678123 Free PMC article.
-
Immunological mechanisms and therapeutic targets of fatty liver diseases.Cell Mol Immunol. 2021 Jan;18(1):73-91. doi: 10.1038/s41423-020-00579-3. Epub 2020 Dec 2. Cell Mol Immunol. 2021. PMID: 33268887 Free PMC article. Review.
-
PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder.J Clin Med. 2021 Apr 18;10(8):1758. doi: 10.3390/jcm10081758. J Clin Med. 2021. PMID: 33919550 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous